Alternatively, 2 mL gives 2.5 mg/mL, making a 2.5 mg dose equal to 1 mL, the full syringe
GLP-1 Oral is taken daily and starts at $239/month
This cardiovascular outcomes trial of semaglutide versus placebo in patients with type 2 diabetes at high cardiovascular risk revealed an unexpected finding: patients receiving semaglutide experienced a statistically significant increase in diabetic retinopathy complications (hazard ratio 1.76, 95% CI 1.112.78, p=0.02)
Ginger Vieira, author, speaker, podcast host, and type 1 diabetes advocate, has shared her personal experience with microdosing semaglutide as part of her diabetes management plan
Both are daily injections the main difference is the dosage